Besunyen Holdings Company Limited, located in Hong Kong, was established in 2000. It is a leading supplier of functional health tea in China. The company is primarily engaged in the research, production, sales, and promotion of functional health tea and medicine. In 2010, Besunyen Holdings Company Limited was listed on the Main Board of the Hong Kong Stock Exchange (stock code HK00926). In recent years, Besunyen has continued to focus on its core business of Besunyen brand Changrun Tea and Changjing Tea, while also introducing a series of functional tea products, including Xianxian Tea and Qingyuan Tea (collectively known as the Four Teas). Since April 2015, Besunyen has been selling Olistat capsules under the LaiLi brand. In October 2017, the company acquired Zhongshan Wanhan Pharmaceutical Co., Ltd. and Zhongshan Wanyuan New Drug Development Co., Ltd., collectively known as "Zhongshan Wanhan". Zhongshan Wanhan's main business is the research, production, and sales of Besunyen brand Olistat capsules and other over-the-counter drugs, expanding Besunyen's product layout from the weight loss health tea market to the weight loss OTC drug market, further covering the weight loss market segment. In April 2021, Besunyen acquired Henan Xueyinghua Pharmaceutical Co., Ltd., which is mainly engaged in the production and sales of soft capsule, hard capsule, and tablet dosage form drugs. The acquisition of Xueyinghua further expands Besunyen's qualifications in pharmaceutical research and development and production, laying a solid foundation for its comprehensive layout and development in the pharmaceutical field. In 2022, Besunyen's offline sales business covered nearly 400,000 non-prescription drug pharmacies and supermarket terminals in 31 provinces, autonomous regions, and municipalities across China through 67 distributors and 96 distributors. The online sales team operates 122 stores on 35 e-commerce platforms to sell the Four Teas, Olistat, and other products of the group. By reaching consumers through various channels, the company aims to improve consumer communication and service. In the future, Besunyen will continue to deepen its development in the health industry, focusing on herbal plants and health preservation. It will expand into new businesses in the fields of "weight loss and weight management" and "intestinal health and gastrointestinal health." The company will continue to establish new channels, develop new products, and explore new business models, striving to create an ecological system in the health industry.
Headquarters
Room 1303, 13/F., China Resources Building, 26 Harbour Road
Hong Kong; Hong Kong;
Contact Details: Purchase the Besunyen Holdings Company Limited report to view the information.
Website: http://ir.besunyen.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service